|Bid||130.10 x 1000|
|Ask||131.95 x 1800|
|Day's Range||129.45 - 131.18|
|52 Week Range||118.62 - 148.99|
|Beta (3Y Monthly)||0.62|
|PE Ratio (TTM)||229.68|
|Earnings Date||Jan 22, 2019|
|Forward Dividend & Yield||3.60 (2.79%)|
|1y Target Est||145.50|
World Economic Forum gathers in Davos, Switzerland, government shutdown continues and earnings week two, here's what you need to know next week.
CNBC's Jim Cramer looks ahead at a busy week of earnings reports that he says might drive investors crazy. Johnson & Johnson, Comcast and Starbucks will be among the companies issuing quarterly results. "I can't recall a time when the forecast will be more important, certainly much more important than the results," Cramer, host of "Mad Money," told viewers.
The major benchmarks made gains, but Netflix fell despite reporting a strong quarter. Elsewhere, Apple and Johnson & Johnson announced a new collaboration.
Apple (AAPL) partners with Johnson & Johnson to conduct multi-year research study for early detection of irregular heart conditions.
Walmart, CVS, American Express, Apple, Johnson & Johnson, Rio Tinto and Tribune Publishing are the companies to watch.
AT&T Inc said Friday it will again buy advertising on Alphabet Inc's YouTube, nearly two years after the U.S. wireless carrier left the video platform when it discovered its ads may have appeared next to inappropriate content. AT&T is one of the largest U.S. brand marketers by total ad spend, according to research firm eMarketer, and its return caps off a tumultuous period for YouTube beginning in March 2017, when major advertisers including Verizon Communications Inc and Johnson & Johnson, left the platform after their ads played during videos featuring hate speech or other disturbing material. As brands eventually returned to YouTube, AT&T remained a major advertiser that held back.
Johnson & Johnson said Thursday that it has joined with Apple Inc. on a research study that will test the Apple Watch’s ability to help detect early irregular heart conditions in certain people before something life-threatening happens. Janssen Pharmaceuticals Inc., which is a part of J&J’s family of research and development companies, will work on the study. The company will use its J&J-developed heart health monitoring app on the latest Apple Watch series.